Tracking JAKs in spondyloarthritis: rationale and expectations.
Department of Rheumatology-Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France.|Immunoregulation Unit, Unité Mixte AP-HP/Institut Pasteur, Institut Pasteur, Paris, France.
Corinne
C
Miceli-Richard
Department of Rheumatology-Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris Descartes University, Paris, France.|Immunoregulation Unit, Unité Mixte AP-HP/Institut Pasteur, Institut Pasteur, Paris, France.|INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France.
Maxime
M
Dougados
D006801:Humans; D009042:Motivation; D010880:Piperidines; D011743:Pyrimidines; D011758:Pyrroles; D025241:Spondylarthritis; D013167:Spondylitis, Ankylosing
D010880:Piperidines; D011743:Pyrimidines; D011758:Pyrroles; C479163:tofacitinib
Chemokines; Cytokines; DMARDs (biologic); Spondyloarthritis; Treatment